1. Home
  2. BWAY vs LWAC Comparison

BWAY vs LWAC Comparison

Compare BWAY & LWAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BWAY
  • LWAC
  • Stock Information
  • Founded
  • BWAY 2003
  • LWAC 2025
  • Country
  • BWAY Israel
  • LWAC United States
  • Employees
  • BWAY N/A
  • LWAC N/A
  • Industry
  • BWAY Medical/Dental Instruments
  • LWAC
  • Sector
  • BWAY Health Care
  • LWAC
  • Exchange
  • BWAY Nasdaq
  • LWAC Nasdaq
  • Market Cap
  • BWAY 280.7M
  • LWAC 299.8M
  • IPO Year
  • BWAY 2019
  • LWAC 2025
  • Fundamental
  • Price
  • BWAY $16.00
  • LWAC N/A
  • Analyst Decision
  • BWAY Strong Buy
  • LWAC
  • Analyst Count
  • BWAY 2
  • LWAC 0
  • Target Price
  • BWAY $18.00
  • LWAC N/A
  • AVG Volume (30 Days)
  • BWAY 50.6K
  • LWAC 33.5K
  • Earning Date
  • BWAY 11-11-2025
  • LWAC 01-01-0001
  • Dividend Yield
  • BWAY N/A
  • LWAC N/A
  • EPS Growth
  • BWAY 679.98
  • LWAC N/A
  • EPS
  • BWAY 0.11
  • LWAC N/A
  • Revenue
  • BWAY $46,084,000.00
  • LWAC N/A
  • Revenue This Year
  • BWAY $335.63
  • LWAC N/A
  • Revenue Next Year
  • BWAY $22.10
  • LWAC N/A
  • P/E Ratio
  • BWAY $54.26
  • LWAC N/A
  • Revenue Growth
  • BWAY 26.50
  • LWAC N/A
  • 52 Week Low
  • BWAY $7.84
  • LWAC $9.81
  • 52 Week High
  • BWAY $17.00
  • LWAC $10.04
  • Technical
  • Relative Strength Index (RSI)
  • BWAY 59.17
  • LWAC N/A
  • Support Level
  • BWAY $14.55
  • LWAC N/A
  • Resistance Level
  • BWAY $15.70
  • LWAC N/A
  • Average True Range (ATR)
  • BWAY 0.69
  • LWAC 0.00
  • MACD
  • BWAY -0.01
  • LWAC 0.00
  • Stochastic Oscillator
  • BWAY 80.77
  • LWAC 0.00

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

About LWAC LightWave Acquisition Corp. Class A Ordinary Shares

LightWave Acquisition Corp is a blank check company.

Share on Social Networks: